UniQ ICTP assay is a convenient tool for monitoring bone metastasis of cancer

Breast, lung and prostate cancers often metastasize to bone. UniQ ICTP test offers a cost-effective way for a timely diagnosis of bone metastases in cancer patients. ICTP is a degradation product of type I collagen, the only collagen type found in bone, and acts an early marker of skeletal metastases. UniQ ICTP test a simple and fast alternative to bone scans without the need for hospitalization.

Read more about UniQ ICTP RIA test in cancer metastases monitoring from our website: UniQ ICTP RIA test